Eosinophilia-Myalgia Syndrome in Germany: An Epidemiologic Review
- 1 July 1994
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 69 (7) , 620-625
- https://doi.org/10.1016/s0025-6196(12)61336-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- L-Tryptophan and the Eosinophilia-Myalgia Syndrome: Current Understanding of the Etiology and PathogenesisJournal of Investigative Dermatology, 1993
- L-Tryptophan and the Eosinophilia-Myalgia Syndrome: Current Understanding of the Etiology and Pathogenesis.Journal of Investigative Dermatology, 1993
- Effect of synthesized constituents in the L-tryptophan product on the differentiation of eosinophils and the induction of IL-6: A possible cause of eosinophilia-myalgia syndromeBiochemical and Biophysical Research Communications, 1991
- Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndromeThe Lancet, 1991
- Characterization of contaminants in EMS-associated L-tryptophan samples by high-performance liquid chromatography.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Characterization of "Peak E," a Novel Amino Acid Associated with Eosinophilia-Myalgia SyndromeScience, 1990
- L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.Journal of Clinical Investigation, 1990
- An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan UseNew England Journal of Medicine, 1990
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990